Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Ukraine is experiencing significant growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Ukraine have shifted towards a greater awareness and understanding of mental health issues, including depressive disorders. As a result, there is an increasing demand for diagnosis, treatment, and support services for individuals suffering from depression. This shift in customer preferences is driven by a growing recognition of the importance of mental health and a desire to improve overall well-being.Trends in the market also contribute to the development of the Depressive Disorders market in Ukraine. One significant trend is the adoption of telemedicine and online therapy services. This trend has been accelerated by the COVID-19 pandemic, which has limited access to in-person healthcare services. The convenience and accessibility of telemedicine services make them an attractive option for individuals seeking help for depressive disorders. Additionally, there is a growing trend towards holistic approaches to mental health, including the use of complementary and alternative therapies. This trend reflects a desire for more personalized and comprehensive treatment options.Local special circumstances in Ukraine further contribute to the growth of the Depressive Disorders market. The country has a high prevalence of depressive disorders, which is likely influenced by factors such as a history of political instability, economic challenges, and social inequalities. These circumstances create a greater need for mental health services and contribute to the demand for treatments and support.Underlying macroeconomic factors also play a role in the development of the Depressive Disorders market in Ukraine. Economic growth and increasing disposable incomes have made mental health services more affordable and accessible to a larger portion of the population. Additionally, government initiatives and healthcare reforms have focused on improving mental health services and increasing access to treatment for depressive disorders. These factors create a favorable environment for the growth of the market.In conclusion, the Depressive Disorders market in Ukraine is experiencing growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increased awareness and understanding of mental health issues, adoption of telemedicine and holistic approaches, high prevalence of depressive disorders, and favorable economic conditions all contribute to the development of the market.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights